【直播】2025年1月生物医药大事讨论

文章预览

各领域专家汇聚在BioSpark Monthly News论坛，交流过去一个月发生的 生物医药领域大事件 。 本月热点 TOPICS 1 .   New Modalities : Sana announces positive clinical results from type 1 diabetes study of islet cell transplantation without immunosuppression;  After Novo Nordisk and Biogen, AbbVie became San Diego biotech Neomorph’s third partner in developing molecular glues； 2 .    Oncology & Autoimmune Diseases： J NJ’s Amivantamab plus Lazertinib showed statistically significant and clinically meaningful OS improvement vs. Osimertinib in 1L locally advanced or metastatic NSCLC with EGFR mutations； Eli Lilly acquired Scorpion’s mutant-selective PI3Ka inhibitor program for $2.5B;  IGM Biosciences halted development of 2 bispecific T cell engagers for autoimmune diseases; 3 .   Metabolic & Neurological Diseases ： Akero Therapeutics reported positive phase 2b results of bivalent FGF21 analog Efruxifermin in MASH patients with biopsy-confi ………………………………